Expression of RPL24 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL24 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1684.4

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1700.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	4887.6
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	4642.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4351.1
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	3969.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3399.3
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3135.6
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3004.8
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2999.5
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2970.4
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2932.1
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2866.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2853.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2804.7
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2761.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2656.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2553.4
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2518.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2516.9
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2310.1
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2288.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2265.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2249.7
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2247.0
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	2226.2
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2211.0
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2208.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2119.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2094.5
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2088.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2068.2
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2038.3
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1990.5
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1986.4
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1978.3
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1974.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1956.5
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1941.3
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1927.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1913.0
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1908.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1899.5
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1869.1
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	1865.9
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1842.8
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1819.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1811.0
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1791.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1789.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1781.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1779.5
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1777.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1753.7
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1740.8
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1732.6
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1715.6
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1706.1
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1690.8
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1688.6
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1684.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1665.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1664.0
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1662.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1634.5
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1605.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1590.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1585.2
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1578.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1564.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1548.6
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1535.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1531.8
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1511.2
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1488.4
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1471.1
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1465.5
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1460.2
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1451.9
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1439.6
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1427.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1422.4
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1415.4
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1400.7
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1397.3
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1392.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1392.5
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1390.3
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1386.9
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1384.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1371.4
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1367.2
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1350.8
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1338.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1333.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1291.8
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1287.6
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1282.5
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1270.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1265.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1251.9
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1251.6
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1239.0
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1237.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1217.5
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1195.6
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1195.4
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1182.5
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1175.0
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1164.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1164.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1163.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1160.9
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1155.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1149.6
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1134.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1123.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1112.9
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1107.4
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1099.0
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1098.5
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1093.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1073.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1070.8
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1063.2
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1059.6
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1054.0
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1040.4
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1029.0
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1009.9
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1009.8
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	993.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	979.3
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	950.6
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	944.4
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	926.7
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	896.4
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	894.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	889.4
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	882.3
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	850.0
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	739.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	604.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL24 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 507.38

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

402.9

Number of samples

Samples

Sample	Description	pTPM
AK142	N, NA, stage:NA, alive, 90 days	806.4
AK051	N, NA, stage:NA, dead, 360 days	696.8
AK066	N, NA, stage:NA, alive, 960 days	672.4
AK124	N, NA, stage:NA, alive, 1920 days	611.2
AK043	N, NA, stage:NA, alive, 660 days	597.4
AK183	N, NA, stage:NA, alive, 360 days	586.2
AK199	N, NA, stage:NA, alive, 1860 days	561.7
AK156	N, NA, stage:NA, dead, 330 days	560.7
AK002	N, NA, stage:NA, dead, 570 days	540.6
AK236	N, NA, stage:NA, dead, 360 days	529.7
AK074	N, NA, stage:NA, alive, 300 days	526.5
AK139	N, NA, stage:NA, dead, 270 days	518.7
AK165	N, NA, stage:NA, alive, 360 days	513.8
AK049	N, NA, stage:NA, dead, 180 days	500.9
AK133	N, NA, stage:NA, dead, 360 days	496.9
AK055	N, NA, stage:NA, dead, 240 days	491.1
AK072	N, NA, stage:NA, dead, 150 days	485.9
AK231	N, NA, stage:NA, dead, 240 days	482.0
AK213	N, NA, stage:NA, alive, 2010 days	480.2
AK071	N, NA, stage:NA, dead, 540 days	478.1
AK178	N, NA, stage:NA, dead, 240 days	476.0
AK173	N, NA, stage:NA, dead, 180 days	474.6
AK098	N, NA, stage:NA, dead, 660 days	458.7
AK041	N, NA, stage:NA, alive, 810 days	457.0
AK153	N, NA, stage:NA, dead, 240 days	440.6
AK003	N, NA, stage:NA, dead, 600 days	431.0
AK185	N, NA, stage:NA, alive, 330 days	429.7
AK195	N, NA, stage:NA, dead, 390 days	409.5
AK188	N, NA, stage:NA, alive, 420 days	407.7
AK216	N, NA, stage:NA, dead, 360 days	401.7
AK030	N, NA, stage:NA, dead, 120 days	373.2
AK149	N, NA, stage:NA, dead, 420 days	366.7
AK015	N, NA, stage:NA, alive, 720 days	360.2
AK158	N, NA, stage:NA, dead, 360 days	356.6
AK205	N, NA, stage:NA, dead, 120 days	346.8
AK100	N, NA, stage:NA, alive, 960 days	337.5
AK053	N, NA, stage:NA, dead, 300 days	321.1
AK089	N, NA, stage:NA, dead, 330 days	320.8
AK227	N, NA, stage:NA, alive, 300 days	320.3
AK076	N, NA, stage:NA, alive, 660 days	316.7
AK117	N, NA, stage:NA, dead, 210 days	288.1
AK088	N, NA, stage:NA, dead, 360 days	286.0
AK102	N, NA, stage:NA, alive, 1740 days	285.0
AK091	N, NA, stage:NA, dead, 210 days	281.3
AK035	N, NA, stage:NA, dead, 210 days	278.5
AK123	N, NA, stage:NA, dead, 180 days	276.0
AK167	N, NA, stage:NA, dead, 180 days	271.0
AK218	N, NA, stage:NA, dead, 180 days	268.7
AK134	N, NA, stage:NA, dead, 360 days	261.3
AK103	N, NA, stage:NA, alive, 1320 days	259.4
AK081	N, NA, stage:NA, dead, 180 days	252.2
AK079	N, NA, stage:NA, dead, 210 days	252.0
AK068	N, NA, stage:NA, alive, 360 days	250.2
AK085	N, NA, stage:NA, alive, 660 days	240.9
AK005	N, NA, stage:NA, dead, 240 days	191.5
AK226	N, NA, stage:NA, dead, 360 days	168.0
AK099	N, NA, stage:NA, dead, 420 days	163.1
AK006	N, NA, stage:NA, dead, 360 days	153.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0182580003	Tumor	1.9
CPT0127480003	Tumor	1.2
CPT0206230003	Tumor	1.1
CPT0162020003	Tumor	1.1
CPT0125510003	Tumor	1.0
CPT0190360004	Tumor	1.0
CPT0218690004	Tumor	0.9
CPT0205450004	Tumor	0.8
CPT0217000004	Tumor	0.8
CPT0206560003	Tumor	0.7
CPT0162100003	Tumor	0.6
CPT0205570003	Tumor	0.6
CPT0123530003	Tumor	0.5
CPT0208980003	Tumor	0.5
CPT0127420003	Tumor	0.5
CPT0125570003	Tumor	0.5
CPT0224540004	Tumor	0.5
CPT0206880003	Tumor	0.5
CPT0218330004	Tumor	0.4
CPT0219080004	Tumor	0.4
CPT0167640003	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0168380003	Tumor	0.3
CPT0093360003	Tumor	0.3
CPT0087570003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0228220003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0064650003	Tumor	0.2
CPT0093510003	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0206000004	Tumor	0.1
CPT0168080003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0189650004	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0206450003	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0217710008	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0168830003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0205780003	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0093450003	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0217100003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0218830004	Tumor	-0.2
CPT0161730003	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0167530003	Tumor	-0.3
CPT0168720003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0217060003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0224600003	Tumor	-0.4
CPT0167860004	Tumor	-0.4
CPT0171580008	Tumor	-0.4
CPT0217190003	Tumor	-0.5
CPT0167970003	Tumor	-0.5
CPT0218770003	Tumor	-0.5
CPT0204400003	Normal	-0.5
CPT0093590003	Tumor	-0.5
CPT0201710003	Tumor	-0.6
CPT0189850004	Tumor	-0.6
CPT0206670004	Tumor	-0.6
CPT0087680003	Tumor	-0.6
CPT0204360003	Normal	-0.6
CPT0167750004	Tumor	-0.6
CPT0092440003	Tumor	-0.6
CPT0224330003	Tumor	-0.6
CPT0204390003	Normal	-0.6
CPT0209440003	Tumor	-0.7
CPT0204380003	Normal	-0.7
CPT0189570004	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0207030003	Tumor	-0.8
CPT0207090003	Tumor	-0.8
CPT0199770003	Tumor	-0.8
CPT0204370003	Normal	-0.8
CPT0204410003	Normal	-0.8
CPT0218960004	Tumor	-0.9
CPT0204420003	Normal	-0.9
CPT0218670003	Tumor	-0.9
CPT0206330003	Tumor	-0.9
CPT0204340003	Normal	-0.9
CPT0168480003	Tumor	-0.9
CPT0104330003	Tumor	-1.0
CPT0104220003	Tumor	-1.0
CPT0189250003	Tumor	-1.1
CPT0190240004	Tumor	-1.1
CPT0162140003	Tumor	-1.2
CPT0204330003	Normal	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA051653
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade